Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 24Burkitt Lymphoma 20Leukemia, Biphenotypic, Acute 12Leukemia, Myeloid, Acute 7Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 6Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 6Osteosarcoma 4Leukemia, Myeloid, Accelerated Phase 4Leukemia 4Blast Crisis 4Lymphoma, Mantle-Cell 3Lymphoma 3Down Syndrome 3Blastic Plasmacytoid Dendritic Cell Neoplasm 3Rhabdoid Tumor 2Recurrence 2Neoplasm Metastasis 2Myeloproliferative Disorders 2Myelodysplastic Syndromes 2Multiple Myeloma 2Lymphoma, Non-Hodgkin 2Leukemia, Myelomonocytic, Juvenile 2Head and Neck Neoplasms 2Anemia, Refractory, with Excess of Blasts 2Waldenstrom Macroglobulinemia 1Urothelial Carcinoma of the Bladder 1Urinary Bladder Neoplasms 1Thrombocythemia, Essential 1Squamous Cell Carcinoma of Head and Neck 1Sezary Syndrome 1

Interventions

Temozolomide 7Vincristine 5Cyclophosphamide 5X-Rays 4Specimen Handling 4Phantoms, Imaging 4Magnetic Resonance Spectroscopy 4Irinotecan 4cabozantinib 3Ifosfamide 3Etoposide 3Doxorubicin 3ulixertinib 2tipifarnib 2tazemetostat 2selpercatinib 2palbociclib 2liposomal doxorubicin 2ivosidenib 2fludarabine 2Topotecan 2Radiation 2Nuclear Medicine Department, Hospital 2LY3023414 2Eflornithine 2Congresses as Topic 2trifluridine tipiracil drug combination 1talazoparib 1silmitasertib 1romiplostim 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Sarcoma, Ewing × Methotrexate × 90 days × Clear all
NCT07321912 2026-05-26

Eflornithine (DFMO) for Ewing Sarcoma and Osteosarcoma

Milton S. Hershey Medical Center

Phase 2 Recruiting
406 enrolled
Sarcoma

Sarcoma, Ewing, Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡